This year has already spent over $20 billions! Eli Lilly (LLY.US) CEO: Will target "blank areas" in pharmaceuticals and continue to pursue larger-scale acquisitions.
智通财经2026/09/29 01:11Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to Zhihu Finance APP, Eli Lilly (LLY.US) CEO Dave Ricks stated that investors can expect Eli Lilly to pursue larger-scale deals, similar to its $7.8 billion acquisition of Centessa Pharmaceuticals Plc, as the company is extensively searching for assets in the "white spaces" of science.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
